Novel sulfonated hydrogel composite with the ability to inhibit proteases and bacterial growth

Journal of Biomedical Materials Research - Part A

Volumn 76, Issue 1, 2006, Pages 35-43

  Vachon, David J ^a   Yager, Dorne R ^b  

^a Aegis Biosciences LLC   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Protease inhibitor; S SEBS; Sulfonated hydrogel; Wound dressing

Indexed keywords

BACTERIA; BLOCK COPOLYMERS; ENZYME INHIBITION; ENZYMES; MEDICAL PROBLEMS; MOISTURE; STERILIZATION (CLEANING);

PROTEASE INHIBITOR; S-SEBS; SULFONATED HYDROGEL; WOUND DRESSING;

HYDROGELS;

COLLAGENASE; COLLAGENASE 2; ELASTASE; NEUTROPHIL COLLAGENASE; NYLON; POLYESTER; POLYMER; PROTEINASE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GROWTH; COMPOSITE MATERIAL; CONTROLLED STUDY; COTTON; ENZYME INHIBITION; GROWTH INHIBITION; HYDROGEL; HYDROPHILICITY; INSTRUMENT STERILIZATION; ION EXCHANGE; MATERIAL STATE; METHODOLOGY; MOISTURE; NONHUMAN; SULFONATION; WOUND DRESSING;

ANTI-BACTERIAL AGENTS; BANDAGES; BIOCOMPATIBLE MATERIALS; DOXYCYCLINE; DRUG DELIVERY SYSTEMS; HUMANS; HYDROGELS; ION EXCHANGE; LEUKOCYTE ELASTASE; MATERIALS TESTING; MATRIX METALLOPROTEINASE 8; PROTEASE INHIBITORS; SULFONIC ACIDS; WOUND HEALING; WOUNDS AND INJURIES;

EID: 30444459010     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbm.a.30440     Document Type: Article

References (28)

1. Mustoe T. Understanding chronic wounds: a unifying hypothesis on their pathogenesis and implications for therapy. Am J Surg 2004;187:65S-70S.
2. National Pressure Ulcer Advisory Panel. Pressure ulcers in America: prevalence, incidence, and implications for the future. An executive summary of the National Pressure Ulcer Advisory Panel monograph. Adv Skin Wound Care 2001;14:208-215.
3. Allman RM, Goode PS, Burst N, Bartolucci AA, Thomas DR. Pressure ulcers, hospital complications, and disease severity: impact on hospital costs and length of stay. Adv Wound Care 1999;12:22-30.
4. Margolis DJ, Bilker W, Santanna J, Baumgarten M. Venous leg ulcer: incidence and prevalence in the elderly. J Am Acad Dermatol 2002;46:381-386.
5. Mekkes JR, Loots MA, Van Der Wal AC, Bos JD. Causes, investigation and treatment of leg ulceration. Br J Dermatol 2003;148:388-401.
6. Dickinson PJ, Carrington AL, Frost GS, Boulton AJ. Neurovascular disease, antioxidants and glycation in diabetes. Diabetes Metab Res Rev 2002;18:260-272.
7. Jack L Jr, Boseman L, Vinicor F. Aging Americans and diabetes. A public health and clinical response. Geriatrics 2004;59:14-17.
8. Lobmann R, Ambrosch A, Schultz G, Waldmann K, Schiweck S, Lehnert H. Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients. Diabetologia 2002;45:1011-1016.
9. Nwomeh BC, Liang HX, Cohen IK, Yager DR. MMP-8 is the predominant collagenase in healing wounds and nonhealing ulcers. J Surg Res 1999;81:189-195.
10. Wysocki AB, Staiano-Coico L, Grinnell F. Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. J Invest Dermatol 1993;101:64-68.
11. Nwomeh BC, Yager DR, Cohen IK. Physiology of the chronic wound. Clin Plast Surg 1998;25:341-356.
12. Yager DR, Zhang LY, Liang HX, Diegelmann RF, Cohen IK. Wound fluids from human pressure ulcers contain elevated matrix metalloproteinase levels and activity compared to surgical wound fluids. J Invest Dermatol 1996;107:743-748.
13. Sipkens K. SEBS-based compounds. Med Device Technol 2000;11:8-13.
14. Cullen B, Watt PW, Lundqvist C, Silcock D, Schmidt RJ, Bogan D, Light ND. The role of oxidised regenerated cellulose/collagen in chronic wound repair and its potential mechanism of action. Int J Biochem Cell Biol 2002;34:1544-1556.
15. Cullen B, Smith R, McCulloch E, Silcock D, Morrison L. Mechanism of action of PROMOGRAN, a protease modulating matrix, for the treatment of diabetic foot ulcers. Wound Repair Regen 2002;10:16-25.
16. Nwomeh BC, Liang HX, Diegelmann RF, Cohen IK, Yager DR. Dynamics of the matrix metalloproteinases MMP-1 and MMP-8 in acute open human dermal wounds. Wound Repair Regen 1998;6:127-134.
17. Golub LM, Lee HM, Lehrer G, Nemiroff A, McNamara TF, Kaplan R, Ramamurthy NS. Minocycline reduces gingival collagenolytic activity during diabetes. Preliminary observations and a proposed new mechanism of action. J Periodontal Res 1983;18:516-526.
18. Golub LM, Ciancio S, Ramamamurthy NS, Leung M, McNamara TF. Low-dose doxycycline therapy: effect on gingival and crevicular fluid collagenase activity in humans. J Periodontal Res 1990;25:321-330.
19. Golub LM, Ramamurthy NS, McNamara TF, Greenwald RA, Rifkin BR. Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs. Crit Rev Oral Biol Med 1991;2:297-321.
20. Sheridan P. From the NIH. Tetracyclines block collagenase activity. JAMA 1984;252:1989-1990.
21. Suomalainen K, Sorsa T, Ingman T, Lindy O, Golub LM. Tetracycline inhibition identifies the cellular origin of interstitial collagenases in human periodontal diseases in vivo. Oral Microbiol Immunol 1992;7:121-123.
22. Nordstrom D, Lindy O, Lauhio A, Sorsa T, Santavirta S, Konttinen YT. Anti-collagenolytic mechanism of action of doxycycline treatment in rheumatoid arthritis. Rheumatol Int 1998;17:175-180.
23. Burns FR, Stack MS, Gray RD, Paterson CA. Inhibition of purified collagenase from alkali-burned rabbit corneas. Invest Ophthalmol Vis Sci 1989;30:1569-1575.
24. Ramamurthy NS, Kucine AJ, McClain SA, McNamara TF, Golub LM. Topically applied CMT-2 enhances wound healing in streptozotocin diabetic rat skin. Adv Dent Res 1998;12:144-148.
25. Ramamurthy NS, McClain SA, Pirila E, Maisi P, Salo T, Kucine A, Sorsa T, Vishram F, Golub LM. Wound healing in aged normal and ovariectomized rats: effects of chemically modified doxycycline (CMT-8) on MMP expression and collagen synthesis. Ann N Y Acad Sci 1999;878:720-723.
26. Steadman R, Irwin MH, St John PL, Blackburn WD, Heck LW, Abrahamson DR. Laminin cleavage by activated human neutrophils yields proteolytic fragments with selective migratory properties. J Leukoc Biol 1993;53:354-365.
27. Malone JD, Richards M, Jeffrey JJ. Recruitment of peripheral mononuclear cells by mammalian collagenase digests of type I collagen. Matrix 1991;11:289-295.
28. Clark RA, Wikner NE, Doherty DE, Norris DA. Cryptic chemotactic activity of fibronectin for human monocytes resides in the 120-kDa fibroblastic cell-binding fragment. J Biol Chem 1988;263:12115-12123.